{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:48:32Z","timestamp":1791474512872,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1053\/j.ajkd.2024.06.012","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T19:41:51Z","timestamp":1722973311000},"page":"55-66.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Representation of Low- and Middle-Income Countries in CKD Drug Trials: A Systematic Review"],"prefix":"10.1053","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3463-6309","authenticated-orcid":false,"given":"Gabriel","family":"Cojuc-Konigsberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Guijosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Moscona-Nissan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Nordmann-Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vianca Anabel","family":"Canaviri-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Braverman-Poyastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"de la Fuente-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisse","family":"Tinajero-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"de las Fuentes Cepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Noyola-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Correa-Rotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Ram\u00edrez-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10225","key":"10.1053\/j.ajkd.2024.06.012_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.ajkd.2024.06.012_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12882-021-02597-3","article-title":"Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990-2019: results from the global burden of disease study 2019","volume":"23","author":"Ke","year":"2022","journal-title":"BMC Nephrol"},{"key":"10.1053\/j.ajkd.2024.06.012_bib3","series-title":"ISN\u2013Global Kidney Health Atlas: A report by the International Society of Nephrology: An Assessment of Global Kidney Health Care Status focusing on Capacity, Availability, Accessibility, Affordability and Outcomes of Kidney Disease","author":"Bello","year":"2023"},{"issue":"2","key":"10.1053\/j.ajkd.2024.06.012_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.kint.2018.11.007","article-title":"World Kidney Day Steering Committee. Burden, access, and disparities in kidney disease","volume":"95","author":"Crews","year":"2019","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2024.06.012_bib5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ekir.2021.03.901","article-title":"Data challenges in addressing chronic kidney disease in low- and lower-middle-income countries","volume":"6","author":"Talbot","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.ajkd.2024.06.012_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41581-019-0212-x","article-title":"Kidney disease trials for the 21st century: innovations in design and conduct","volume":"16","author":"Herrington","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2024.06.012_bib7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/j.ajkd.2013.10.043","article-title":"The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.gov","volume":"63","author":"Inrig","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2024.06.012_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.kisu.2017.10.012","article-title":"Global capacity for clinical research in nephrology: a survey by the International Society of Nephrology","volume":"8","author":"Okpechi","year":"2018","journal-title":"Kidney Int Suppl (2011)"},{"issue":"10","key":"10.1053\/j.ajkd.2024.06.012_bib9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41581-023-00756-3","article-title":"Increasing diversity and inclusion in nephrology clinical trials","volume":"19","author":"Young","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2024.06.012_bib10","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41591-022-01781-8","article-title":"Patient reported outcome assessment must be inclusive and equitable","volume":"28","author":"Calvert","year":"2022","journal-title":"Nat Med"},{"issue":"8","key":"10.1053\/j.ajkd.2024.06.012_bib11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrneph.2014.98","article-title":"Clinical trials: ISN-ACCTS: global initiatives to improve clinical research","volume":"10","author":"Levin","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1053\/j.ajkd.2024.06.012_bib12","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"9","key":"10.1053\/j.ajkd.2024.06.012_bib13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jclinepi.2014.12.017","article-title":"Using data sources beyond PubMed has a modest impact on the results of systematic reviews of therapeutic interventions","volume":"68","author":"Halladay","year":"2015","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.ajkd.2024.06.012_bib15","article-title":"Clinical trial design and dissemination: comprehensive analysis of Clinicaltrials.gov and PubMed data since 2005","volume":"361","author":"Zwierzyna","year":"2018","journal-title":"BMJ"},{"issue":"D1","key":"10.1053\/j.ajkd.2024.06.012_bib18","doi-asserted-by":"crossref","first-page":"D1307","DOI":"10.1093\/nar\/gkab918","article-title":"NCATS Inxight Drugs: a comprehensive and curated portal for translational research","volume":"50","author":"Siramshetty","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1053\/j.ajkd.2024.06.012_bib19","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"6","key":"10.1053\/j.ajkd.2024.06.012_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2019-001940","article-title":"Inequities in the global representation of sites participating in large, multicentre dialysis trials: a systematic review","volume":"4","author":"Smyth","year":"2019","journal-title":"BMJ Glob Health"},{"issue":"1","key":"10.1053\/j.ajkd.2024.06.012_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.ajkd.2007.10.047","article-title":"CKD and poverty: a growing global challenge","volume":"53","author":"Hossain","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"15","key":"10.1053\/j.ajkd.2024.06.012_bib25","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2024.06.012_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1053\/j.ajkd.2024.06.012_bib27","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1053\/j.ajkd.2024.06.012_bib28","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1053\/j.ajkd.2024.06.012_bib29","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1053\/j.ajkd.2024.06.012_bib30","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1093\/ndt\/gfad009","article-title":"The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease","volume":"38","author":"Rossing","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2024.06.012_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/dom.12808","article-title":"The effect of liraglutide on renal function: a randomized clinical trial","volume":"19","author":"Von Scholten","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1053\/j.ajkd.2024.06.012_bib32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.kint.2023.12.003","article-title":"Mind the gap in kidney care: translating what we know into what we do","volume":"105","author":"Luyckx","year":"2024","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2024.06.012_bib33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41581-023-00782-1","article-title":"New and emerging therapies for diabetic kidney disease","volume":"20","author":"Correa-Rotter","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2024.06.012_bib34","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41581-023-00745-6","article-title":"Inequities in kidney health and kidney care","volume":"19","author":"Vanholder","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2024.06.012_bib35","first-page":"14","article-title":"Association between quality of clinical trials and human development index in heart failure using JADAD scale","volume":"5","author":"Hassan","year":"2015","journal-title":"Princ Pract Clin Res"},{"issue":"3","key":"10.1053\/j.ajkd.2024.06.012_bib36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijcard.2013.08.101","article-title":"The wealth of nations and the dissemination of cardiovascular research","volume":"169","author":"Winnik","year":"2013","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1053\/j.ajkd.2024.06.012_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-003758","article-title":"How global is global health research? A large-scale analysis of trends in authorship","volume":"6","author":"Dimitris","year":"2021","journal-title":"BMJ Glob Health"},{"key":"10.1053\/j.ajkd.2024.06.012_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13012-015-0217-1","article-title":"Gaps between research and public health priorities in low income countries: evidence from a systematic literature review focused on Cambodia","volume":"10","author":"Goyet","year":"2015","journal-title":"Implement Sci"},{"issue":"6","key":"10.1053\/j.ajkd.2024.06.012_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000619","article-title":"Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated","volume":"4","author":"Lang","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2024.06.012_bib40","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S2666-7568(21)00089-1","article-title":"The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults","volume":"2","author":"Flood","year":"2021","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"10.1053\/j.ajkd.2024.06.012_bib41","doi-asserted-by":"crossref","DOI":"10.1080\/17441692.2023.2229890","article-title":"Under-representation of low and middle income countries (LMIC) in the research literature: ethical issues arising from a survey of five leading medical journals: have the trends changed?","volume":"18","author":"Woods","year":"2023","journal-title":"Glob Public Health"},{"issue":"9925","key":"10.1053\/j.ajkd.2024.06.012_bib42","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0140-6736(13)62711-7","article-title":"Nephrology in developing countries: the ISN\u2019s story","volume":"383","author":"Feehally","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.ajkd.2024.06.012_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2017-000380","article-title":"Chronic kidney disease and the global NCDs agenda","volume":"2","author":"Neuen","year":"2017","journal-title":"BMJ Glob Health"},{"issue":"1","key":"10.1053\/j.ajkd.2024.06.012_bib44","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.kisu.2019.11.002","article-title":"Framework for establishing integrated kidney care programs in low- and middle-income countries","volume":"10","author":"Tonelli","year":"2020","journal-title":"Kidney Int Suppl (2011)"},{"issue":"6","key":"10.1053\/j.ajkd.2024.06.012_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-009067","article-title":"The use, misuse and overuse of the \u2018low-income and middle-income countries\u2019 category","volume":"7","author":"Lencucha","year":"2022","journal-title":"BMJ Glob Health"},{"issue":"7","key":"10.1053\/j.ajkd.2024.06.012_bib46","doi-asserted-by":"crossref","first-page":"e901","DOI":"10.1016\/S2214-109X(21)00145-5","article-title":"A\u00a0call for reforms in global health publications","volume":"9","author":"Sharma","year":"2021","journal-title":"Lancet Glob Health"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638624009028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638624009028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T20:23:49Z","timestamp":1753993429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638624009028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0272638624009028"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2024.06.012","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Representation of Low- and Middle-Income Countries in CKD Drug Trials: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2024.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}